Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -5 of 5
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
10/10/2008
 
First Published:
7/24/2007
1.
Phase II Pilot Study of Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine in Male Patients With HIV-1 Infection
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
NCI
AMC-052
052, AMC-052, NCT00513526
2.
Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Prevention
Active
16 to 26
Pharmaceutical / Industry
2007_538
V503-001, NCT00543543
First Published:
4/24/2008
3.
Pilot Study of the Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Virus-Like-Particle Recombinant Vaccine in HIV-Positive Women in India
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Biomarker/Laboratory analysis, Prevention
Approved-not yet active
18 and over
NCI
AMC-054
AMC-054, NCT00667563
4.
Pilot Study to Determine the Safety and Efficacy of Gardasil Against the Human Papilloma Virus (HPV) in HIV-Infected Men
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Diagnostic, Prevention
Active
18 and over
Other
#33245
NCT00666107
5.
Acceptance of Human Papillomavirus Vaccination in Postpartum Women
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Prevention
Approved-not yet active
18 to 26
Other
IRB-AAAD1877
NCT00730704
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute